Naltiazem
Naltiazem (Ro 23-6152) is a thiazepinone-type calcium antagonist. Naltiazem inhibits platelet aggregation in vitro and in vivo[1].
Product Specifications
CAS Number
108383-95-5
Product Name Alternative
Ro 23-6152
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/naltiazem.html
Smiles
CN(C)CCN1C2=CC=C(C=CC=C3)C3=C2S[C@@H](C4=CC=C(C=C4)OC)[C@H](C1=O)OC(C)=O
Molecular Formula
C26H28N2O4S
Molecular Weight
464.58
References & Citations
[1]L A Sordahl, et al. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152) . J Cardiovasc Pharmacol. 1991 Oct;18 (4) :504-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx6613-500gEcoli 500 µg (E. coli)
Recombinant Chlamydophila Trachomatis CTA_0378 Protein (aa 1-196)
Sign In for Pricing
View Details MBS1147550-01 0.02 mg (E-Coli)
Recombinant Pseudomonas aeruginosa Urease accessory protein UreG (ureG)
Sign In for Pricing
View Details MBS1147550-02 0.1 mg (E-Coli)
Recombinant Pseudomonas aeruginosa Urease accessory protein UreG (ureG)
Sign In for Pricing
View Details